NodThera
Little Chesterford
About NodThera
NodThera is a Cambridge (UK) headquartered biotech engaged in innate immune/ inflammasome research. Their leading project is focused on developing inhibitors of the NLRP3 inflammasome for the treatment of inflammatory and neuroinflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $95.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2020)
- Website: nodthera.com
- Phone: +44 (0) 1223 608130
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/nodthera-19892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.